Free Trial Free TrialFree Trial

More results...

Filter by Content types
Regulatory data
Regulatory reports
Market reports
News analysis

Alerts LATEST ALERTS

  • Finland Smoke-free Finland 2030 network suggests limits for pouches…
  • France National Tobacco Control Programme 2023-2027 published…
  • World COP10 rescheduled to February 2024…
  • Kuwait National Assembly to discuss GCC heated tobacco tax agreement…
  • Russia Tax Code amendment bill signed by president…
  • New Zealand Health organisations against repeal of Smokefree Environments Act…
  • Czech Republic Nicotine pouch and heated tobacco tax bill signed by president…
  • Italy ADM updates price and tax list for heated tobacco…
  • Canada Government releases 2023 Fall Economic Statement
  • United Kingdom MP asks if there will be a debate on smoking and vaping bill…
  • Greece Public consultation on tax bill ends today…
  • Ireland Public consultation launched over tobacco regulation…
View all
News analysis

The FDA’s new philosophy: ‘We need to take a fresh look at nicotine’

Written by || 31st July 2017 || News analysis | Combustibles | Politics & policy | Vapour | North America United States

Scott Gottlieb, commissioner of the US FDA, appeared on Friday to go further than any federal official – or most politicians – previously had in supporting alternative nicotine products for harm reduction ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us

Related contents

FDA moves on nicotine levels in combustibles, leaving e-cigs alone
FDA squeeze on nicotine in combustibles could hasten Big Tobacco move to HnB
New views on nicotine: now the FDA is reconsidering NRT, too

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis


    See more


    By signing up you agree to our Privacy Policy. 

    © 2023 Tamarind Media Limited (T/A TobaccoIntelligence)

    TobaccoIntelligence does not provide legal, strategic or investment advice. Tamarind Media Limited, the publisher of TobaccoIntelligence, does not accept any liability or responsibility for information or views published.